Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Free Report) to a sell rating in a research report released on Wednesday. Other analysts also recently issued research reports about the company. Piper Sandler reduced their price objective on Codexis from $14.00 to $10.00 and set an overweight rating for the company in a research report on […]
Investment Analysts’ upgrades for Wednesday, January 10th: Antero Midstream (NYSE:AM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. AMETEK (NYSE:AME) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. American Tower (NYSE:AMT) was upgraded by analysts at StockNews.com from a hold rating to a […]
On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its investment portfolio by reducing its stake in Codexis Inc (NASDAQ:CDXS). Following this transaction, Baillie Gifford (Trades, Portfolio)'s remaining holding in Codexis Inc totals 3,419,093 shares, which represents a 4.90% ownership in the company and a 0.01% position in Baillie Gifford (Trades, Portfolio)'s portfolio.
/PRNewswire/ -- The "Global Synthetic Biology Market: Analysis By Product Type, By Technology, By Application, By End Users, By Region, Size and Trends with...
Trellus Management Company LLC decreased its position in shares of Codexis, Inc. (NASDAQ:CDXS – Free Report) by 12.5% during the third quarter, HoldingsChannel reports. The firm owned 220,000 shares of the biotechnology company’s stock after selling 31,460 shares during the period. Trellus Management Company LLC’s holdings in Codexis were worth $416,000 at the end of […]